BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200408T090000
DTEND;TZID=America/Vancouver:20200408T110000
DTSTAMP:20260414T050252
CREATED:20200330T190906Z
LAST-MODIFIED:20200330T190906Z
UID:8697-1586336400-1586343600@scienceinseattle.com
SUMMARY:Webinar: Deciphering the Cell Cycle - The Role of Cell Cycle Control in Cancer
DESCRIPTION:A fundamental hallmark of cancer is uncontrolled cell division. In an effort to understand this process\, researchers have focused on characterizing the signaling proteins that govern the regulation of the cell cycle. Specific cyclin dependent kinases (CDKs) and their activating cyclin subunits are desirable therapeutic targets because they regulate a cell’s transition through different phases and checkpoints in the cycle\, providing opportunities to block dysregulated cell division and therefore block tumor growth. In recent years\, researchers have seen success with FDA-approved treatments that target CDK4/6 at the G1/S checkpoint of the cell cycle in estrogen receptor-positive and HER2-negative breast cancers. Many clinical trials are ongoing\, not only to test new drugs\, but also to examine the effects of combinatorial therapies on various cancer types. In their presentations\, our speakers will discuss the intricate interactions between key cell-cycle proteins and how therapeutic interventions can target their activity to fight common cancers.\nDuring the webinar viewers will: \n\nHear about exciting advancements in understanding how CDKs regulate cell cycle control\nDiscover how new CDK inhibitors can be used in combination with other therapeutics to target cancer\nLearn about similarities and differences in critical cell cycle signaling pathways in different cancer types\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes \nYou can also view part 1 of this series.
URL:https://scienceinseattle.com/event/webinar-deciphering-the-cell-cycle-the-role-of-cell-cycle-control-in-cancer/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Deciphering-the-cell-cycle-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200408T090000
DTEND;TZID=America/Vancouver:20200408T110000
DTSTAMP:20260414T050252
CREATED:20200330T190906Z
LAST-MODIFIED:20200330T190906Z
UID:25545-1586336400-1586343600@scienceinseattle.com
SUMMARY:Webinar: Deciphering the Cell Cycle - The Role of Cell Cycle Control in Cancer
DESCRIPTION:A fundamental hallmark of cancer is uncontrolled cell division. In an effort to understand this process\, researchers have focused on characterizing the signaling proteins that govern the regulation of the cell cycle. Specific cyclin dependent kinases (CDKs) and their activating cyclin subunits are desirable therapeutic targets because they regulate a cell’s transition through different phases and checkpoints in the cycle\, providing opportunities to block dysregulated cell division and therefore block tumor growth. In recent years\, researchers have seen success with FDA-approved treatments that target CDK4/6 at the G1/S checkpoint of the cell cycle in estrogen receptor-positive and HER2-negative breast cancers. Many clinical trials are ongoing\, not only to test new drugs\, but also to examine the effects of combinatorial therapies on various cancer types. In their presentations\, our speakers will discuss the intricate interactions between key cell-cycle proteins and how therapeutic interventions can target their activity to fight common cancers.\nDuring the webinar viewers will: \n\nHear about exciting advancements in understanding how CDKs regulate cell cycle control\nDiscover how new CDK inhibitors can be used in combination with other therapeutics to target cancer\nLearn about similarities and differences in critical cell cycle signaling pathways in different cancer types\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes \nYou can also view part 1 of this series.
URL:https://scienceinseattle.com/event/webinar-deciphering-the-cell-cycle-the-role-of-cell-cycle-control-in-cancer-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Deciphering-the-cell-cycle-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200408T090000
DTEND;TZID=America/Vancouver:20200408T110000
DTSTAMP:20260414T050252
CREATED:20200330T190906Z
LAST-MODIFIED:20200330T190906Z
UID:26510-1586336400-1586343600@scienceinseattle.com
SUMMARY:Webinar: Deciphering the Cell Cycle - The Role of Cell Cycle Control in Cancer
DESCRIPTION:A fundamental hallmark of cancer is uncontrolled cell division. In an effort to understand this process\, researchers have focused on characterizing the signaling proteins that govern the regulation of the cell cycle. Specific cyclin dependent kinases (CDKs) and their activating cyclin subunits are desirable therapeutic targets because they regulate a cell’s transition through different phases and checkpoints in the cycle\, providing opportunities to block dysregulated cell division and therefore block tumor growth. In recent years\, researchers have seen success with FDA-approved treatments that target CDK4/6 at the G1/S checkpoint of the cell cycle in estrogen receptor-positive and HER2-negative breast cancers. Many clinical trials are ongoing\, not only to test new drugs\, but also to examine the effects of combinatorial therapies on various cancer types. In their presentations\, our speakers will discuss the intricate interactions between key cell-cycle proteins and how therapeutic interventions can target their activity to fight common cancers.\nDuring the webinar viewers will: \n\nHear about exciting advancements in understanding how CDKs regulate cell cycle control\nDiscover how new CDK inhibitors can be used in combination with other therapeutics to target cancer\nLearn about similarities and differences in critical cell cycle signaling pathways in different cancer types\nHave the opportunity to ask questions during the live broadcast.\n\nThis webinar will last for approximately 60 minutes \nYou can also view part 1 of this series.
URL:https://scienceinseattle.com/event/webinar-deciphering-the-cell-cycle-the-role-of-cell-cycle-control-in-cancer-3/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinseattle.com/wp-content/uploads/sites/4/2020/03/Deciphering-the-cell-cycle-webinar.jpg
END:VEVENT
END:VCALENDAR